Banco Santander S.A. grew its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 26.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,663 shares of the company's stock after purchasing an additional 2,818 shares during
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
INDIANAPOLIS--(BUSINESS WIRE)--Americans want healthcare to be easier to understand, more personalized and less frustrating, according to a national survey conducted by The Harris Poll and commissioned by Elevance Health. The survey found: 82% of Americans say some part of healthcare information feels like a "foreign language." Nearly half (45%) say that they have made a healthcare decision they later regretted because they did not understand the basics of healthcare. 79% believe AI can improve.
ELV eyes a Medicaid margin recovery in 2027 as reimbursement rates improve, but elevated medical costs and uneven state adjustments remain key hurdles.
Elevance Health (NYSE: ELV - Get Free Report) and Alignment Healthcare (NASDAQ: ALHC - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings and valuation. Insider and Institutional Ownership 89.2% of Elevance Health
Aberdeen Group plc grew its stake in Elevance Health, Inc. (NYSE: ELV) by 6.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 298,585 shares of the company's stock after acquiring an additional 17,561 shares during the quarter. Aberdeen Group plc owned
Elevance Health NYSE: ELV expects adjusted earnings per share to grow at least 12% in 2027 from its recently increased 2026 baseline of at least $26.75, Chief Financial Officer Mark Kaye said at a UBS conference.
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned indicative Long-Term Issue Credit Ratings of “bbb+” (Good) to senior unsecured issues, “bbb” (Good) to subordinated issues and “bbb-” (Good) to preferred stock issues to the recently filed shelf registrations of Elevance Health, Inc. (Elevance Health) (Indianapolis, IN) [NYSE: ELV]. The outlook assigned to these Credit Ratings (ratings) is stable. Concurrently, AM Best has withdrawn the ratings of the previous shelf registration, which expire.
Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and Revvity (RVTY). But which of these two companies is the best option for those looking for undervalued stocks?